In order to determine the eects of mismatch repair (MMR) de®ciencies in sporadic colorectal carcinomas, 45 such cancers were examined using a sensitive method called crypt isolation technique. Loss of heterozygosity (LOH) in the MSH2 or MLH1 gene was more frequently observed in replication error (RER) (+) carcinomas than in RER (7) carcinomas, which implied that loss of one normal allele could partly aect repair capacity. MSH2 gene defects at both alleles were observed in two carcinomas, which showed severe repair de®ciencies. Interestingly, unlike the situation observed in the p53 gene, the MSH2 and MLH1 genes did not show complete LOH. Novel crypt isolation-based subpopulation (CISP) analysis demonstrated that at least two distinct carcinoma subpopulations existed in most carcinomas that showed incomplete LOH; one with and one without LOH. In one carcinoma that had germline mutation and somatic incomplete LOH of the MSH2 gene, the mutator phenotype was only observed in populations aected in both alleles. Thus, the MSH2 gene appears to possess the two hits mechanism of tumor suppressor genes. However, unlike the tumor suppressor genes, MMR gene defects lead to a unique mode of colorectal tumorigenesis characterized by intratumoral heterogeneity.
Introduction
DNA replication error (RER) phenotype has been observed in hereditary nonpolyposis colorectal cancer (HNPCC) and some sporadic colorectal cancer (Ionov et al., 1993; Aaltonen et al., 1993) . These RER phenotypes are related to functional loss of mismatch repair (MMR) genes, including the MSH2, MLH1, PMS1 and PMS2 genes (Fishel et al., 1993; Bronner et al., 1994; Papadopoulos et al., 1994; Nicolaides et al., 1994) . The mechanism by which this occurs is thought to be identical to the two hits model of classical tumor suppressor genes (Knudson, 1971) .
Colorectal carcinomas with RER phenotype are distinct entity within colorectal carcinomas for the following clinicopathological and biological features: they are characterized by (a) location in proximal colon, (b) mucin production and poor dierentiation, (c) better prognosis, (d) diploid or near-diploid status, and (e) lower rates of loss of heterozygosity (LOH) of tumor suppressor genes (Thibodeau et al., 1993; Lothe et al., 1993; Kim et al., 1994) . These observations prompted us to speculate a unique pathomechanism of MMR de®ciencies in colorectal tumorigenesis.
The aim of the present study was to examine alterations in the MSH2 and MLH1 genes and to estimate their eects on the mutator phenotype characterized by RER phenotype or TGF bRII gene mutation in sporadic colorectal carcinomas. Forty-®ve sporadic colorectal carcinomas were examined using a crypt isolation technique that allows the complete separation of neoplastic crypts from nonneoplastic stromal cells (Nakamura et al., 1993 (Nakamura et al., , 1994 Yoshida et al., 1996) . This technique has been applied to both ow cytometric (Nakamura et al., 1994) and genetic analysis (Habano et al., 1996) of colorectal carcinomas and oers advantages over conventional methods. In particular, the technique improves the sensitivity of LOH analysis for tumor suppressor genes (Habano et al., 1996) . Although previous studied have described the average characteristics of tumor DNA, the nature of heterogeneity within tumors has yet to be fully clari®ed. Therefore, a novel method called crypt isolation-based subpopulation (CISP) analysis was designed in the present study in order to obtain genetic information of each tumor crypt, which is the minimal unit of monoclonal subpopulations (Griths et al., 1988; Endo et al., 1995) . We believe that the present study using CISP analysis is the ®rst to clearly elucidate and de®ne the nature of MMR de®ciencies in colorectal carcinomas.
Results

LOH of MSH2 and MLH1 genes
LOH status was quantitatively evaluated in 45 sporadic colorectal carcinomas by analysing¯uorescently labeled polymerase chain reaction (PCR) products and calculating a q-value as described previously (Habano et al., 1996) . The q-value (04q41) re¯ected the average ratio of actual paired gene copy number in carcinoma cells. For the positive and negative controls, p53 and randomly selected loci (D10S197 and D11S904) were used, respectively (Hemminki et al., 1994) . The q-value distribution at each locus is shown in Figure 1 . An obvious bimodal distribution was observed at the p53 locus, because most cases fell into two groups with respect to q-value (04q50.1 and q50.5). Therefore, an LOH-positive case was de®ned as that with a q-value of less than 0.5 ( Figure 1a ). This was consistent with the results of negative markers in which all except one case showed a q-value greater than 0.50 (Figure 1b) .
Loss of MSH2 (2p16) and MLH1 (3p21) genes was examined using three and four¯anking microsatellite markers, respectively. LOH (+) cases were de®ned as those with a q-value less than 0.5 for at least one marker at each gene locus. Unlike the situation observed for the p53 gene, the MSH2 and MLH1 genes frequently showed incomplete LOH (0.14q50.5) (Figure 2c, d) . Therefore, bimodal distribution of q-value at the MSH2 and MLH1 loci was less obvious than that at the p53 locus (Figure 3 ). This incomplete LOH was not due to contamination with nonneoplastic cells, since the same materials showed complete LOH at the p53 locus (q50.1, Figure 2e , f). In combination with the results of the negative markers (D10S197 and D11S904), such incomplete LOH (0.14q50.5) was found to be speci®c to the MSH2 and MLH1 loci. We assumed that LOH of the MSH2 and MLH1 genes tended to be heterogeneous within tumors. According to the above cut-o q-value (q50.5), the frequency of LOH was 21% at the MSH2 locus and 20% at the MLH1 locus ( Figure 3 ).
Mutation of MSH2 and MLH1 genes
All MSH2 and MLH1 exons were screened for mutations using PCR-single strand conformation polymorphism (SSCP) and direct sequencing. Intron primers¯anking each entire exon were used. Two cases showed the same mutation in the intron 5 splicing site of the MSH2 gene (AGgta?AGgtt). This base substitution was germline in one case and somatic in the other and has been frequently detected in HNPCC patients (Lu et al., 1996) . In addition, both carcinomas of these cases had lost the other normal allele, resulting in MSH2 gene defects at both alleles. Figure 1 Distribution of q-values at (a) p53 locus and (b) D10S197 and D11S904 loci. Most cases fell into two groups (04q50.1 and 0.54q) at p53 locus, resulting in obvious bimodal distribution. Incidence of p53 LOH was evaluated to be 67% when cut-o q-value was de®ned at 0.50. At D10S197 and D11S904 loci, all except one case showed a q-value more than 0.50 Figure 2 Representative electropherograms of three loci in PCR ± LOH analysis. N1 and N2 were two major peaks in normal mucosa, while C1 and C2 were corresponding peaks in carcinomas. Case 56C showed complete LOH (q=0.08) at D3S1611 locus (a), (b). Case 28C showed incomplete LOH (q=0.38) at D2S123 locus (c), (d), but showed complete LOH (q=0.06) at p53 locus (e), (f). The RER phenotype was observed in ten cases (22%) in which at least one of the 11 microsatellite markers tested was aected. The incidence of RER was similar to those in other series of colorectal carcinomas reported previously (RuÈ scho et al., 1995) . We examined the association between loss of MMR genes and RER phenotype (Table 1 ). All cases were classi®ed into two groups according to the number of RER-present markers and the incidence of LOH was compared between the groups. In the RER (+) group (n51), LOH in the MSH2 and MLH1 genes was identi®ed in three of eight (38%) and three of nine (33%) carcinomas, respectively, while in the RER (7) group, LOH in the MSH2 and MLH1 genes was identi®ed in six of 34 (18%) and six of 35 (17%) carcinomas, respectively. Thus, LOH occurred more frequently in the RER (+) group than the RER (7) group, although this dierence was not statistically signi®cant because of the small number of cases in each group. The results implied that loss of one allele could aect MMR capacity and contribute to the RER phenotype. On the other hand, LOH in the p53 gene occurred equally between the two groups (67% versus 72%).
The TGF b RII gene mutation, which is thought to be a good indicator of MMR de®ciency Parsons et al., 1995) , was also examined. Three cases in the present study (7%) showed the same somatic frame shift mutations within the polyadenine cluster region (A 10 to A 9 ). An association between MMR gene defects and mutator phenotype is summarized in Table 2 . There were two cases in which the MSH2 gene was inactivated at both alleles. Both of these cases exhibited an intense RER phenotype with a relatively high number of RER-present markers (n53) and also possessed TGF b RII gene mutations. In addition, a TGF b RII gene mutation was detected in carcinoma tissue but not in normal mucosa of patient 57C who had a germ line mutation of the MSH2 gene. These results showed that a TGF b RII gene mutation occurred in cells with MSH2 gene defects at both alleles, although no abnormalities in the MSH2 and MLH1 genes were identi®ed in one case (501C) that exhibited an intense RER phenotype (n=11).
Crypt isolation-based subpopulation (CISP) analysis
To prove that the incomplete LOH detected in the MSH2 and MLH1 loci resulted primarily from intratumoral heterogeneity, CISP analysis was performed on the isolated crypts. Twenty neoplastic crypts were isolated from 57C carcinoma in which germline mutation and somatic incomplete LOH (q=0.49) were detected in the MSH2 gene (Table 2, Figure 4a and b). Genomic DNA was obtained from each crypt and was then analysed individually for LOH. As shown in Figure  4c and d, the 57C carcinoma consisted of at least two subpopulations with respect to LOH status at the D2S391 locus. Population-1 retained heterozygosity and population-2 showed complete LOH. Therefore, loss of the MSH2 gene occurred in this case and the alteration was heterogeneous within this carcinoma. The evidence also eliminated the possibility that the allelic imbalance detected in this PCR-based analysis was due to primary gene ampli®cation of only one allele.
Whether both 57C tumor subpopulations demonstrated the mutator phenotype was also examined. As shown in Figure 4 , both populations revealed distinct mutator phenotype status. LOH (+) population-2 exhibited both RER phenotype at the p53 locus ( Figure 4h ) and the TGF b RII gene mutation ( Figure  4 l), while LOH (7) population-1 did not exhibit either (Figure 4g, k) . Thus, only tumor subpopulations aected at both parental MSH2 genes revealed the mutator phenotype. These ®ndings support a two hits inactivation mechanism for the MSH2 gene.
CISP analysis was applied to other cases that showed incomplete LOH at the MSH2 or MLH1 locus. Most carcinomas of these cases similarly consisted of at least two subpopulations with respect (Habano et al., 1996) . Therefore, the status of the MSH2 and MLH1 genes could be accurately estimated in the present study. Another advantage is that, using CISP analysis, genetic information of pure tumor cells in a single crypt could be obtained. Since a single crypt is most likely composed of a monoclonal population, we are able to elucidate the nature of intratumoral heterogeneity by analysing individual crypts. A microdissection technique has been employed for this purpose (Pan et al., 1995) , but the poor quality of the DNA obtained and contamination with stromal cells has frequently prevented accurate analysis. Cytogenetic analysis, such as, in situ hybridization can provide direct and immediate information regarding changes in gene copy number in single cells (Sauter et al., 1994; Koyayashi et al., 1996) . However, incomplete hybridization of probes has often complicated the analysis.
Most signi®cantly, this novel approach can be applied to a variety of genetic studies unlike conventional cytogenetic LOH analysis. CISP analysis is the ®rst to prove the existence of genetic heterogeneity in colorectal carcinomas. Allelic imbalances at the MSH2 and MLH1 loci were identi®ed in 21% and 20% of cases, respectively, of 45 sporadic colorectal carcinomas. Quantitative assessment using q-values revealed that the most abnormal cases showed incomplete LOH (0.14q50.5), which was not observed in the p53 and other randomly selected loci, but which were speci®c to the MSH2 and MLH1 loci. The subsequent CISP analysis provided evidence that the incomplete LOH re¯ected intratumoral heterogeneity with respect to LOH status. There has been no systematic approach for the assessment of these borderline cases, because previous studies could not eliminate the possibility of contaminating nonneoplastic cells and also described the average characteristics of tumor DNA. We have shown, for the ®rst time, that MSH2 and MLH1 gene defects are extremely heterogeneous within tumors. Although intratumoral heterogeneity in variant status of microsatellite sequences (Jacoby et al., 1995) , LOH of tumor suppressor genes (Boland et al., 1995) or DNA ploidy (Sasaki et al., 1988) has been reported in colorectal carcinomas, these alterations are unlikely important for the development of heterogeneity. Therefore, to our knowledge, this is the ®rst evidence for special genetic events that potentially lead to intratumoral heterogeneity. The heterogeneous situation has not been observed in classical tumor suppressor genes, which have shown complete LOH among most positive cases. The heterogeneous disposition also implied that defects in the MSH2 and MLH1 genes could not provide the accelerated growth advantage of tumor cells to the colorectal carcinomas as eectively as defects in tumor suppressor genes. This result supports previous studies that show a significantly lower proliferative activity in RER (+) tumors (Bocker et al., 1996) . We think that MMR de®ciencies do not necessarily accelerate the growth advantage of tumor cells and that this is one of the reasons for the improved prognosis of RER tumors (Thibodeau et al., 1993; Lothe et al., 1993) . The heterogeneous characteristics of tumor cells with MMR de®ciencies as well as contamination by nonneoplastic cells, may have led previous investigators to miss the borderline cases and underestimate the incidence of MMR gene defects.
In the present study, loss of the MSH2 or MLH1 gene was more frequently detected in RER (+) carcinomas than RER (7) carcinomas. Therefore, loss of one allele in the MSH2 and MLH1 genes could aect repair capacity and contribute to RER phenotype in a dose-dependent manner as reported for tumor suppressor genes . A previous report demonstrated that LOH frequently occurs at the MLH1 locus in RER (+) sporadic colorectal carcinomas but rarely at the MSH2 locus (Tomlinson et al., 1996) , whereas LOH was identi®ed to the same level in the present study.
On the other hand, TGF b RII gene mutations and intense RER phenotype preferentially occurred in carcinomas that contained inactivated MSH2 genes at both alleles (57C and 18C). This implies that more crucial defects in the MSH2 gene depend on the two Figure 4 MMR status and mutator phenotypes in case 57C. LOH of D2S391 locus, RER phenotype at p53 locus and TGF b RII mutation were examined for normal mucosa (a), (e), (i) and carcinoma (b), (f), (j). Subpopulation analysis was performed on population-1 (c), (g), (k) and population-2 (d), (h), (l). N1 and N2 were two major peaks in normal mucosa, while C1 and C2 were corresponding peaks in carcinomas. A10 and A9 revealed the number of adenine repeats in TGF b RII gene of normal and mutant, respectively. LOH (+) population-2 exhibited both RER phenotype and TGF b RII gene mutation, whereas neither was exhibited in LOH (7) population-1 hits inactivation mechanism evident in classical tumor suppressor genes. Interestingly, no abnormalities were identi®ed in the MSH2 and MLH1 genes in carcinoma tissue of patient 501C, which exhibited intense RER phenotype and TGF b RII gene mutation. We assume that the other MMR defects, such as in the PMS1, PMS2, GTBP or MSH3 genes (Eshleman and MarkowõÂ tz, 1996) or an as yet unknown gene are involved in this carcinoma.
To investigate MMR de®ciencies in detail, CISP analysis of specimen 57C was performed. A family history ful®lling HNPCC criteria (Vasen et al., 1991) in this patient's kindred could not be con®rmed, although the patient has a germline mutation in the MSH2 gene. We considered this case to be a de novo germline mutation, as demonstrated previously Moslein et al., 1996) . This case was considered to be a suitable model to elucidate the mechanism of MMR gene defects, since a germline mutation of the MSH2 gene had occurred in the normal mucosa and the eect of the second hit (LOH) on this gene during tumorigenesis could be estimated. The CISP analysis proved that the incomplete LOH at the MSH2 locus (q=0.49) in this carcinoma resulted from intratumoral heterogeneity with respect to LOH status. Other oncogenic alterations in the p53, APC, DCC and Kras genes were not detected in this carcinoma. Therefore, genetically, the possibility that the LOH-negative population consisted of nonneoplastic cells could not be eliminated. However, this was a most unlikely situation because only tumor populations showing morphological features of carcinoma crypts were selected under a dissecting microscope. Moreover, the mutator phenotypes such as RER phenotype and TGF b RII gene mutations were identi®ed in tumor populations in which the MSH2 gene defects occurred at both alleles. This supports that MMR gene defects are based on a two hits inactivation mechanism and tend to result in genetic heterogeneity in colorectal carcinomas.
Two dierent genetic pathways in colorectal tumorigenesis have recently been reported: one is an LOH pathway and the other is an RER pathway. Accumulation of loss of tumor suppressor genes plays an important role in the former pathway, whereas a similar alteration is rarely detected in the latter (Eshleman et al., 1996; Konishi et al., 1996) . However, in the present study, RER (+) carcinomas had lost the p53 gene as frequently as RER (7) carcinomas. The RER (+) carcinomas were apparently divided into two groups as reported previously (34); one was a mild RER (+) group (14n43) and the other a severe RER (+) group (n510), although both carcinomas frequently demonstrated genetic heterogeneity. We speculated that the mild RER (+) carcinomas had concomitantly lost MMR genes through the typical LOH pathway and then partially conserved their MMR capacities in the remaining normal allele. Therefore, these`pseudo' RER (+) carcinomas may have exhibited the mild RER phenotype. On the other hand, the severe`genuine' RER (+) carcinomas, which were a minor subgroup of sporadic RER (+) carcinomas, likely shared similar biological characteristics with HNPCC carcinomas. Alternatively, the phenotypic dierence between mild and severe carcinomas might simply re¯ect the result caused by defects in dierent MMR genes. This hypothesis can be supported by a recent study which suggests substrate recognition speci®city of MMR genes (Risinger et al., 1996) .
In the present study, MSH2 and MLH1 gene defects were found to lead to a unique mode of colorectal tumorigenesis in which the acquired hypermutabilities most often exhibited a high degree of genetic heterogeneity. Because such a mutator phenotype can lead to not only an advantageous mutation but also a deleterious or lethal mutation for tumor cells, MMR gene defects may not necessarily provide for clonal expansion. Even if a tumor cell once acquired a selective growth advantage, subsequent lethal mutations may occur in the progeny cells. Therefore, tumor cells aected in one of the MMR gene alleles may be preferentially detected over those aected in both alleles in RER carcinomas. The MMR gene defects were presumably based on a classical two hits model observed in tumor suppressor genes, but the unique heterogeneous characteristics were apparently speci®c to MMR gene defects.
Materials and methods
Tissue specimens
Forty-®ve tissue specimens were obtained from 44 patients (30 males and 14 females) with primary colorectal carcinomas. Corresponding tissue specimens were obtained from normal mucosa located distal to the tumor. All specimens were surgically resected at Iwate Medical University Hospital, Morioka, Japan, betwen 1993 and 1995. None of the patients had a family history of colorectal cancer nor ful®lled the Amsterdam criteria (Vasen et al., 1991) for the HNPCC family.
Crypt isolation and DNA extraction
Crypt isolation and DNA extraction were carried out as previously described (Habano et al., 1996) . DNA was obtained from more than 50 single crypts of each carcinoma specimen. If neoplastic crypts formed clusters, DNA was obtained from more than 50 pieces of these clusters.
PCR ± LOH analysis
To detect allelic deletions at the MSH2 and MLH1 gene loci, PCR ± LOH analysis using an automated DNA sequencer was performed (Habano et al., 1996) . Genomic DNA was ampli®ed using markers¯anking a microsatellite CA repeat at the MSH2 or the MLH1 loci, including D2S391, CA21 and D2S123 for the MSH2 locus and D3S1619, D3S1611, D3S1298 and D3S1029 for the MLH1 locus (Hemminki et al., 1994; Gyapay et al., 1994) . A p53 marker and randomly selected D10S197 and D11S904 markers (Cawkwell et al., 1994; Hemminki et al., 1994; Gyapay et al., 1994) were used for positive and negative controls, respectively. Each sense primer was labeled with 6-FAM, TET or HEX¯uorescent dye. Analysis was performed using a model 373A automated¯uorescent DNA sequencer and GENESCAN 2 672 (Version 1.2.2-1, Perkin-Elmer Cetus, Norwalk, Connecticut). LOH status was quantitatively evaluated by calculating q-value as described previously (Cawkwell et al., 1993) . The q-value was calculated from the allele ratios that were the means of two repeat assay. A tumor sample with a ratio of less than or equal to 0.50 for at least one marker was de®ned as a positive case of LOH at the locus. RER tumors, which complicate the interpretation of allelic losses due to their elevated new alleles, were excluded from this analysis. By titrating analysis (Hahn et al., 1995) , PCR conditions were established that allowed a linear relationship between the real gene copy number ratio and ampli®ed fragmentspeci®c peak area ratio at each marker to be obtained.
PCR ± SSCP analysis
To screen for mutations in exons 1 ± 16 of the MSH2 gene and exons 1 ± 19 of the MLH1 gene, nonRI PCR ± SSCP analysis was performed using a temperature controller as previously described (Habano et al., 1996) with a slight modi®cation; PCR products were obtained from each exon Han et al., 1995) and electrophoresed at 260 V at 238C for 3 ± 4 h through a 7.5% polyacrylamide gel containing 50 mM Tris-base, 50 mM boric acid, 1 mM EDTA and 2.5% glycerol. DNA fragments that showed mobility shifts according to SSCP analysis were subjected to direct sequencing using dye-labeled dideoxynucleoside triphosphates as terminators and analysed using the automated DNA sequencer (Habano et al., 1996) .
Analysis for RER and TGF b RII gene mutation
Eleven microsatellite markers, including the ten used above for LOH analysis and the AluVpA marker (Young et al., 1995) were used for RER assessment. Detection and analysis were performed according to the same procedure as noted in PCR ± LOH analysis. RER-positive tumors were de®ned by the presence of microsatellite alteration in at least one locus. To assess the TGF b RII gene mutation, PCR products¯anking a 10 bp polyadenine tract at codons 125 ± 128 were analysed by the same procedure as noted in PCR ± LOH analysis. Tumor samples with an insertion or deletion within this poly A tract were de®ned as positive cases of mutation.
CISP analysis
To identify intratumoral heterogeneity, more than twenty neoplastic crypts were isolated from each carcinoma. Genomic DNA was obtained from each crypt and LOH, RER phenotype and TGF b RII gene mutation were examined individually for each crypt using the methods described above.
Statistical analysis
Fisher's Exact Test was used to compare frequencies of LOH at the MSH2 or MLH1 locus between RER(+) and RER(7) carcinomas. Signi®cance was established at the P50.05 level.
